Shares Of Halozyme Up 14% Following FDA Removal Of Hold On PEGPH20
June 05, 2014 at 11:29 AM EDT
Shares of Halozyme Therapeutics (NASDAQ: HALO) at one point spiked more than 20 percent following the U.S. Food and Drug ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.